APA (7th ed.) Citation

Blauvelt, A., Boguniewicz, M., Brunner, P. M., Luna, P. C., Biswas, P., DiBonaventura, M., . . . Cameron, M. C. Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: Improvement in signs and symptoms of atopic dermatitis and quality of life. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Blauvelt, Andrew, Mark Boguniewicz, Patrick M. Brunner, Paula C. Luna, Pinaki Biswas, Marco DiBonaventura, Saleem A. Farooqui, Ricardo Rojo, and Michael C. Cameron. Abrocitinib Monotherapy in Investigator’s Global Assessment Nonresponders: Improvement in Signs and Symptoms of Atopic Dermatitis and Quality of Life. Taylor & Francis Group.

MLA (9th ed.) Citation

Blauvelt, Andrew, et al. Abrocitinib Monotherapy in Investigator’s Global Assessment Nonresponders: Improvement in Signs and Symptoms of Atopic Dermatitis and Quality of Life. Taylor & Francis Group.